Dongliang Chen

Title: Innovations of Dongliang Chen in Cancer Cell Proliferation Inhibition

Introduction

Dongliang Chen is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of biotechnology, particularly in the development of methods to inhibit the proliferation of cancer cells. His innovative approach combines the use of albumin peptides, showcasing his expertise in the intersection of biochemistry and medical science.

Latest Patents

Dongliang Chen holds a patent for the "Preparation method of albumin peptide combination having the action of inhibiting the proliferation of cancer cells." This invention outlines a method that involves mixing albumin and water, followed by a series of steps including heating, pH adjustment, and enzymatic hydrolysis. The resulting albumin peptide combination has been found to be more effective in inhibiting cancer cell proliferation compared to using the seed individually. The process is noted for its simplicity and efficiency.

Career Highlights

Throughout his career, Dongliang Chen has worked with various organizations, including Nascent Peptide Biotechnology Limited. His work has focused on developing innovative solutions in the field of cancer treatment, contributing to advancements in medical biotechnology.

Collaborations

Dongliang Chen has collaborated with notable professionals in his field, including Yang Zhang and Cong Zhou. These collaborations have likely enhanced the research and development of his innovative methods.

Conclusion

Dongliang Chen's contributions to the field of cancer research through his innovative patent demonstrate his commitment to advancing medical science. His work not only highlights the potential of albumin peptides but also paves the way for future research in cancer treatment.